Morning Market Losers
January 07, 2015 at 09:50 AM EST
KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO) shares dipped 66.67% to $0.61 after the company reported top-line data from phase 2 study ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.